Executives On The Move: CRISPr Therapeutics, Syndax Pharmaceuticals and More
Executive Summary
Recent executive changes in the industry include C-suite changes at Sundax Pharmaceuticals and NRx Pharmaceuticals. Meanwhile, new directors were appointed at Verve Therapeutics and CRISPr Therapeutics, among others.